Zobrazeno 1 - 10
of 21
pro vyhledávání: '"XUE-PENG HE"'
Autor:
Kai Yang, Bing Liu, Peng Chen, Fang Wang, Zhi Guo, Hui‑Ren Chen, Yuan Zhang, Xiao‑Dong Liu, Jin‑Xing Lou, Xue‑Peng He
Publikováno v:
Molecular Medicine Reports.
Angiogenesis is important in pathophysiological processes, including the pathogenesis of acute monocytic leukemia (AML). MicroRNA‑21 (miR‑21) is overexpressed and exhibits oncogenic activity in cancer. However, the biological mechanism underlying
Autor:
Zhi, Guo, Hui-Ren, Chen, Xiao-Dong, Liu, Kai, Yang, Jing-Xing, Lou, Yuan, Zhang, Peng, Chen, Xue-Peng, He
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 24(6)
To investigate the efficacy and safety of haploidentical allo-HSCT in combination of reduced intensity preconditioning combined with cyclophosphamid (CTX)-induced immune tolerance after transplanitation for treatment of severe aplastic anemia (SAA).A
Autor:
Chun, Tong, Zhi, Guo, Jing-Xing, Lou, Xiao-Dong, Liu, Kai, Yang, Xue-Peng, He, Peng, Chen, Yuan, Zhang, Hui-Rren, Chen
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 24(1)
To evaluate the relationship between T lymphocyte subsets and the incidence of graft-versus-host disease (GVHD) and its clinical significance of monitoring the changes of T lymphocyte subsets dynamicly on 1, 3, 6, 12 month after allogeneic hematopoie
Publikováno v:
Advanced Materials Research. 346:670-674
A simultaneous phase shift interferometry was proposed to determine the time delay accurately in the pulse laser pump-probe detecting. The relevant optical system formed by four light interference channels was designed and optimized based on Jones th
Autor:
Zhi Guo, Hui‑Ren Chen, Tian‑Yang Zhang, Xue‑Peng He, Jin‑Xing Lou, Kai Yang, Hong‑Yan Gao, Xiaodong Liu
Publikováno v:
Biomedical reports. 5(5)
The aim of the present study was to construct a chimeric adenovirus (Ad)5/F35 co-expressing human CD4O ligand (CD4OL) and interleukin (IL)-2 (Ad5/F35 CD40L-IL-2). The infection efficiency to human monocyte-derived dendritic cells (Mo-DCs), expression
Autor:
Feng, Zhu, Hui-Ren, Chen, Zhi, Guo, Xiao-Dong, Liu, Xue-Peng, He, Jing-Xing, Lou, Kai, Yang, Yuan, Zhang, Peng, Chen
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 22(5)
This study was purposed to evaluate the curative efficacy of second allogeneic hematopoietic stem cell transplantation (allo-HSCT) after failure of the first allo-HSCT in aplastic anemia patients, the cause of implant failure after allo-HSCT and clin
Autor:
Zhi, Guo, Hui-Ren, Chen, Xiao-Dong, Liu, Jing-Xing, Lou, Kai, Yang, Yuan, Zhang, Peng, Chen, Xue-Peng, He
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 22(5)
This study was aimed to explore the effect and feasibility of reduced conditioning intensity allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of relapsed ETO positive acute myeloid leukemia (AML) patients. Fifteen cases
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 22(5)
This study was purposed to investigate the therapeutic efficacy of haploidentical allogeneic hemopoietic stem cell transplantation (allo-HSCT) for severe aplastic anemia (SAA), and evaluate the safety of this treatment by retrospective analysis. A to
Autor:
Zhi, Guo, Hui-Ren, Chen, Xiao-Dong, Liu, Jing-Xing, Lou, Kai, Yang, Yuan, Zhang, Peng, Chen, Shi-Yao, Wang, Xue-Peng, He
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 21(2)
This study was purposed to explore the efficacy and feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation (allo-HSCT) in the treatment of multiple myeloma (MM). Three patients with MM from January 2011 to January 2012 in
Autor:
Hui-Ren, Chen, Jing-Xing, Lou, Yuan, Zhang, Xiao-Dong, Liu, Kai, Yang, Peng, Chen, Bing, Liu, Xue-Peng, He, Zhi, Guo, Dan, Liu
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 20(4)
Objective of this study was to evaluate the efficacy and safety of haploidentical or unrelated donor hematopoietic stem cell transplantation (HSCT) for patients with severe aplastic anemia (SAA). Twenty patients with SAA received allogeneic HSCT from